ARCTIC/ PLARTPR00012 /
| 2024-05-02 10:13:14 AM | Chg. +0.02 | Volume | Bid10:13:20 AM | Ask10:13:20 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 20.54PLN | +0.10% | 2,961 Turnover: 60,886.24 |
20.52Bid Size: 254 | 20.60Ask Size: 2,737 | 1.42 bill.PLN | 4.87% | 5.75 |
GlobeNewswire
04-29
Arctic Wolf Named a Leader in 2024 IDC MarketScape for Worldwide Managed Detection and Response Serv...
GlobeNewswire
03-28
Dynagas LNG Partners LP Reports Results for the Three Months and Year Ended December 31, 2023
GlobeNewswire
03-26
WILD ANIMAL SAFARI® PINE MOUNTAIN CELEBRATES REMARKABLE RECOVERY ONE YEAR AFTER DEVASTATING TORNADO
GlobeNewswire
03-19
Arctic Wolf Expands AWS Marketplace Availability as Demand for Security Operations Increases Globall...
GlobeNewswire
03-19
Arctic Semiconductor Unveils SilverWings: The World's Premier Low-Power All-in-One RF Transceiver
GlobeNewswire
03-18
Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
GlobeNewswire
03-17
Captain Planet Foundation Raises More Than $800,000 at Annual Gala Honoring Environmental Heroes Jos...
GlobeNewswire
03-13
NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare ...
GlobeNewswire
03-12
Arctic Therapeutics and Nacuity Pharmaceuticals Announce European Medicines Agency Approval to Initi...
GlobeNewswire
03-11
Thumzup Welcomes Hope and Sesame® Sesamemilk to AdTech Platform as Brand Launches in Costco Warehous...
GlobeNewswire
03-11
Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th
GlobeNewswire
03-05
Eyenovia Congratulates Formosa Pharmaceuticals on FDA Approval of Clobetasol Propionate Ophthalmic S...
